Cited by 53HIV/AIDS drug development and treatmentHIV Research and TreatmentSynthesis of Tetrazole Derivatives

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Design, Synthesis, and Biological Evaluation of Novel Hybrid Dicaffeoyltartaric/Diketo Acid and Tetrazole-Substituted l-Chicoric Acid Analogue Inhibitors of Human Immunodeficiency Virus Type 1 Integrase

Abstract

Fourteen analogues of the anti-HIV-1 integrase (IN) inhibitor L-chicoric acid (L-CA) were prepared. Their IC(50) values for 3'-end processing and strand transfer against recombinant HIV-1 IN were determined in vitro, and their cell toxicities and EC(50) against HIV-1 were measured in cells (ex vivo). Compounds 1-6 are catechol/β-diketoacid hybrids, the majority of which exhibit submicromolar potency against 3'-end processing and strand transfer, though only with modest antiviral activities. Compounds 7-10 are L-CA/p-fluorobenzylpyrroloyl hybrids, several of which were more potent against strand transfer than 3'-end processing, a phenomenon previously attributed to the β-diketo acid pharmacophore. Compounds 11-14 are tetrazole bioisosteres of L-CA and its analogues, whose in vitro potencies were comparable to L-CA but with enhanced antiviral potency. The trihydroxyphenyl analogue 14 was 30-fold more potent than L-CA at relatively nontoxic concentrations. These data indicate that L-CA analogues are attractive candidates for development into clinically relevant inhibitors of HIV-1 IN.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm1010594

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 66

  1. Charpentier C., 2008, HIV Med., 9, 765, 10.1111/j.1468-1293.2008.00628.x · DOI
  2. Cooper D. A., 2008, N. Engl. J. Med., 359, 355, 10.1056/NEJMoa0708978 · DOI
  3. Goethals O., 2008, J. Virol., 82, 10366, 10.1128/JVI.00470-08 · DOI
  4. Malet I., 2008, Antimicrob. Agents Chemother., 52, 1351, 10.1128/AAC.01228-07 · DOI
  5. Marinello J., 2008, Biochemistry, 47, 9345, 10.1021/bi800791q · DOI
  6. Shimura K., 2008, J. Virol., 82, 764, 10.1128/JVI.01534-07 · DOI
  7. Kobayashi M., 2008, Antiviral Res., 80, 213, 10.1016/j.antiviral.2008.06.012 · DOI
  8. LaFemina R. L., 1992, J. Virol., 66, 7414, 10.1128/jvi.66.12.7414-7419.1992 · DOI
  9. Robinson W. E., 1998, Infect. Med., 15, 129
  10. Lewinski M. K., 2005, Adv. Genet., 55, 147, 10.1016/S0065-2660(05)55005-3 · DOI
  11. Robinson W. E., 1996, Mol. Pharmacol., 50, 846, 10.1016/S0026-895X(25)09385-X · DOI
  12. King P. J., 1998, J. Virol., 72, 8420, 10.1128/JVI.72.10.8420-8424.1998 · DOI
  13. Zhu K., 1999, J. Virol., 73, 3309, 10.1128/JVI.73.4.3309-3316.1999 · DOI
  14. Hazuda D. J., 2000, Science, 287, 646, 10.1126/science.287.5453.646 · DOI · Paper page
  15. Robinson W. E., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 6326, 10.1073/pnas.93.13.6326 · DOI
  16. Espeseth A. S., 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 11244, 10.1073/pnas.200139397 · DOI · Paper page
  17. Fikkert V., 2004, AIDS (London), 18, 2019, 10.1097/00002030-200410210-00006 · DOI
  18. Hazuda D. J., 2004, Proc. Natl. Acad. Sci. U.S.A., 101, 11233, 10.1073/pnas.0402357101 · DOI
  19. Hombrouck A., 2008, Antimicrob. Agents Chemother., 52, 2069, 10.1128/AAC.00911-07 · DOI
  20. Garvey E. P., 2008, Antimicrob. Agents Chemother., 52, 901, 10.1128/AAC.01218-07 · DOI
  21. King P. J., 2003, Virology, 306, 147, 10.1016/S0042-6822(02)00042-9 · DOI
  22. King P. J., 1999, J. Med. Chem., 42, 497, 10.1021/jm9804735 · DOI
  23. Reinke R. A., 2002, J. Med. Chem., 45, 3669, 10.1021/jm010359d · DOI
  24. Charvat T. T., 2006, Bioorg. Med. Chem., 14, 4552, 10.1016/j.bmc.2006.02.030 · DOI
  25. Zeng L.-F., 2008, Bioorg. Med. Chem. Lett., 16, 7777, 10.1016/j.bmc.2008.07.008 · DOI
  26. Patil S., 2007, Bioorg. Med. Chem., 15, 1212, 10.1016/j.bmc.2006.11.026 · DOI
  27. Marchand C., 2002, J. Biol. Chem., 277, 12596, 10.1074/jbc.M110758200 · DOI
  28. Reinke R. A., 2004, Virology, 326, 203, 10.1016/j.virol.2004.06.005 · DOI
  29. Liljebris C., 2002, J. Med. Chem., 45, 785, 10.1021/jm011100y · DOI
  30. Burg D., 2002, Bioorg. Med. Chem. Lett., 12, 1579, 10.1016/S0960-894X(02)00247-0 · DOI
  31. Marco J. A., 1995, An. Quim., 91, 103
  32. Baderschneider B., 2001, J. Agric. Food Chem., 49, 2788, 10.1021/jf010396d · DOI
  33. Perez-Magarino S., 2008, J. Agric. Food Chem., 56, 11560, 10.1021/jf802100j · DOI
  34. Chelucci G., 1990, Gazz. Chim. Ital., 120, 731
  35. Stephens C. R., 1955, J. Am. Chem. Soc., 77, 1701, 10.1021/ja01611a102 · DOI
  36. Obenland C. O., 1966, Inorg. Synth., 8, 53, 10.1002/9780470132395.ch15 · DOI
  37. Fischer E., 1913, Ber. Dtsch. Chem. Ges., 46, 1138, 10.1002/cber.191304601150 · DOI
  38. D’Accorso N. B., 1982, Anal. Asoc. Quim. Argent., 70, 793
  39. Horenstein B. A., 1989, J. Am. Chem. Soc., 111, 6242, 10.1021/ja00198a040 · DOI
  40. Lee D. J., 2006, Antimicrob. Agents Chemother., 50, 134, 10.1128/AAC.50.1.134-142.2006 · DOI
  41. Lee D. J., 2004, J. Virol., 78, 5835, 10.1128/JVI.78.11.5835-5847.2004 · DOI
  42. Chow S. A., 1997, Methods (San Diego, CA, U. S.), 12, 306, 10.1006/meth.1997.0484 · DOI
  43. Montefiori D. C., 1988, J. Clin. Microbiol., 26, 231, 10.1128/jcm.26.2.231-235.1988 · DOI
  44. Maurin C., 2006, Bioorg. Med. Chem., 14, 2978, 10.1016/j.bmc.2005.12.039 · DOI
  45. Xu Y.-S., 2006, Chin. J. Chem., 24, 1086, 10.1002/cjoc.200690203 · DOI
  46. Lin Z., 1999, J. Med. Chem., 42, 1401, 10.1021/jm980531m · DOI
  47. Sechi M., 2004, J. Med. Chem., 47, 5298, 10.1021/jm049944f · DOI
  48. Pais G. C. G., 2002, J. Med. Chem., 45, 3184, 10.1021/jm020037p · DOI
  49. Wai J. S., 2000, J. Med. Chem., 43, 4923, 10.1021/jm000176b · DOI
  50. Lei X., 2006, Abstracts of Papers
  51. Tchertanov L., 2007, J. Med. Chem., 50, 1133, 10.1021/jm061375j · DOI
  52. Maignan S., 1998, J. Mol. Biol., 282, 359, 10.1006/jmbi.1998.2002 · DOI
  53. Chen J. C.-H., 2000, Proc. Natl. Acad. Sci. U.S.A., 97, 8233, 10.1073/pnas.150220297 · DOI · Paper page
  54. Goldgur Y., 1998, Proc. Natl. Acad. Sci. U.S.A., 95, 9150, 10.1073/pnas.95.16.9150 · DOI
  55. Goldgur Y., 1999, Proc. Natl. Acad. Sci. U.S.A., 96, 13040, 10.1073/pnas.96.23.13040 · DOI
  56. Bujacz G., 1997, J. Biol. Chem., 272, 18161, 10.1074/jbc.272.29.18161 · DOI
  57. Kawasuji T., 2006, Bioorg. Med. Chem., 14, 8420, 10.1016/j.bmc.2006.08.043 · DOI
  58. Engelman A., 1995, J. Virol., 69, 5908, 10.1128/jvi.69.9.5908-5911.1995 · DOI
  59. Alves C. N., 2007, Chem.—Eur. J., 13, 7715, 10.1002/chem.200700040 · DOI
  60. Healy E. F., 2009, J. Mol. Graphics Modell., 27, 584, 10.1016/j.jmgm.2008.09.011 · DOI
  61. Sotriffer C. A., 2000, J. Med. Chem., 43, 4109, 10.1021/jm000194t · DOI
  62. Barreto G., 2009, Environ. Mol. Mutagen., 50, 771, 10.1002/em.20500 · DOI
  63. Maurin C., 2004, Tetrahedron, 60, 6479, 10.1016/j.tet.2004.06.030 · DOI
  64. Jitoe A., 1993, Phytochemistry, 32, 357, 10.1016/S0031-9422(00)94994-X · DOI
  65. Adeva M., 2000, J. Org. Chem., 65, 3387, 10.1021/jo991815x · DOI
  66. Berend L., 1902, J. Prakt. Chem., 173, 290, 10.1002/prac.19020650121 · DOI

Metadata

Authors
Crosby, D. C., Lei, X., Gibbs, C. G., McDougall, B. R., Robinson, W. E., & Reinecke, M. G.
Affiliations
  • Department of Pathology and Laboratory Medicine
  • Texas Christian University (US)
Corresponding author
Reinecke, Manfred G.
Venue
Journal of Medicinal Chemistry
Published
2010-10-26
Volume
53
Issue
22
Pages
8161-8175
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2331728824
Cited by
53
References
3
Citations by year
2026: 3 · 2025: 5 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 7 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 4
FWCI
2.28
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service (5R0IAI063973)
  • National Institute of Allergy and Infectious Diseases (R21AI054305)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis of Tetrazole Derivatives
Keywords
HIV-1 integrase inhibitors, 3' end processing, strand transfer, antiviral activity, cytotoxicity, pharmacophore
MeSH terms
Caffeic Acids, Cell Line, Humans, Keto Acids, Structure-Activity Relationship, Succinates, Tetrazoles, Virology, HIV-1, HIV Integrase, HIV Integrase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review